Catégories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
661
Antibiotics
247
Bioactive Small Molecules
714
Aroma Chemicals
203
Biochemicals
998
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
254
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
323
Ion-Pair Reagents
24
Ligands
79
Organics
1288
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
96
Research Organics & Inorganics
747
Salts
282
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
291
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
91
Water Analysis
11
Nimodipine
(18892332 | 66085-59-4)
CAS: | 66085-59-4 |
---|---|
Formule moléculaire: | C21H26N2O7 |
Masse moléculaire: | 418.44 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | | |
18892332-1g | 1g | £30.90 | |
Commande en vrac |
18892332-1g | 1g | €43.30 | |
Commande en vrac |
18892332-1g | 1g | $46.40 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 18892332 | ||||
Product Name | Nimodipine | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 66085-59-4 | ||||
Molecular Formula | C21H26N2O7 | ||||
Molecular Weight | 418.44 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933399990 |
Spécifications du produit
Identification | H-NMR, MS | ||||
Loss on Drying | ≤0.5% | ||||
Assay | 98.5%~101.5% | ||||
Residue on Ignition | ≤0.1% | ||||
Appearance of Solution | Clear | ||||
Storage | Protected from light | ||||
Appearance | A light yellow crystalline powder | ||||
Specific Rotaion | -0.10°~+0.10° |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|